Equillium Share Price

Equillium Share Price

NASDAQ: EQ | Micro Cap | Healthcare
$1.09
-$0.13 (-10.66%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Equillium Stock Performance

Open
$1.14
Prev. Close
$1.22
Circuit Range
N/A
Day Range
$1.06 - $1.21
Year Range
$0.81 - $3.47
Volume
34,848
Average Traded
$1.11

Equillium Share Price Today

As of 19 November 2026, Equillium, Inc.'s share price is $1.09. The stock opened at $1.14, compared to its previous close of $1.22. During today's trading session, Equillium, Inc.'s share price traded between $1.06 and $1.21, with an average price of $1.14. Over the past 52 weeks, the stock has recorded a high of $3.47 and a low of $0.81. In terms of performance, Equillium, Inc.'s share price has declined by 62.28% over the last six months and is up 19.78% on a year-on-year basis.

Equillium Share Price Chart

Line chart of the Equillium price trend over the selected period. The price fell overall, ranging from 1.06 to 1.21, ending at 1.09.
$1.06$1.21
L
Show Current Price
H

Equillium Stock Fundamentals & Key Indicators

Market Cap
$62.46M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.22
Revenue (TTM)
$0.00
Return On Equity (TTM)
-34.84%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-21.16%

Equillium Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$3.78-$5.30-$4.69-$4.58
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-40.21%11.51%2.35%

Equillium Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$15.76$36.08$41.10$0.00
Net Profit-$62.43-$13.34-$8.07-$22.40
Net Profit Margin-396.13%-36.97%-19.64%N/A
Income ChangeN/A78.63%39.51%-177.57%

Equillium Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.850.631.181.69
Current Assets31.0424.9849.3576.74
Total Assets31.8925.650.5378.42
Non Current Liabilities0.360.190.3814.44
Current Liabilities2.936.3627.5732.04
Total Liabilities3.296.5427.9646.48
Shareholders' Equity28.619.0622.5731.94

Equillium Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-22.75-19.03-21.78-31.78
Investing4.4613.81-4.7641.73
Financing30.430.16-9.23-1.22

About Equillium

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Equillium Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.39
$1.09
-20.65%
Oct 2026
$1.58
$1.38
-14.55%
Sep 2026
$2.24
$1.61
-33.81%
Aug 2026
$2.17
$2.44
+11.67%
Jul 2026
$3.15
$2.19
-31.50%
Jun 2026
$2.92
$3.19
+10.38%
May 2026
$2.05
$2.89
+40.98%
Apr 2026
$2.03
$2.05
+3.54%
Mar 2026
$1.73
$1.98
+8.79%
Feb 2026
$1.44
$1.82
+28.17%
Jan 2026
$1.53
$1.42
-8.39%
Dec 2025
$0.89
$1.55
+70.33%

Equillium Share Price FAQs